View Clinical Trial (Medical Research Study)
A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction - NCT00437424-44106(Clinical Trial 163122)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Clleveland |
|
State:
|
|
OH |
| Zip Code: |
|
44106 |
| Conditions: |
|
Carcinoma, Hepatocellular |
| Purpose: |
|
The primary purpose of this protocol is to determine the effect of BMS-582664 on patients
with hepatocellular carcinoma with varying levels of hepatic impairment
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Subjects with a biopsy proven advanced solid tumor
- Subjects with a biopsy proven diagnosis of hepatocellular carcinoma conforming to
child pugh classifications A, B, or C |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 11, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|